Novo Nordisk A/S

NYSE (USD): Novo Nordisk A/S (NVO)

Last Price

87.75

Today's Change

+6.65 (8.189%)

Day's Change

86.58 - 89.97

Trading Volume

24,175,249

Overview

Market Cap

359 Billion

Shares Outstanding

4 Billion

Avg Volume

7,535,158

Avg Price (50 Days)

97.44

Avg Price (200 Days)

121.71

PE Ratio

29.66

EPS

2.96

Earnings Announcement

05-Feb-2025

Previous Close

81.10

Open

89.97

Day's Range

86.5805 - 89.97

Year Range

78.17 - 148.15

Trading Volume

24,238,873

Price Change Highlight

1 Day Change

8.25%

5 Day Change

9.82%

1 Month Change

0.48%

3 Month Change

-22.94%

6 Month Change

-33.29%

Ytd Change

0.31%

1 Year Change

-16.56%

3 Year Change

83.97%

5 Year Change

187.46%

10 Year Change

288.80%

Max Change

54768.75%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment